Novavax (GB:0A3S)
LSE:0A3S
Holding GB:0A3S?
Track your performance easily

Novavax (0A3S) Financial Statements

15 Followers

Novavax Financial Overview

Novavax's market cap is currently ―. The company's EPS TTM is $-2.766; its P/E ratio is -3.76; Novavax is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 415.48M$ 93.86M$ 291.34M$ 186.99M$ 424.43M
Gross Profit$ 369.24M$ 34.65M$ -52.43M$ 186.99M$ 424.43M
EBIT$ 167.19M$ -141.18M-$ -126.42M$ 63.18M
EBITDA$ 178.33M$ -129.03M-$ -115.10M$ 73.25M
Net Income Common Stockholders$ 166.52M$ -147.55M$ -178.39M$ -130.78M$ 58.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.05B$ 480.59M$ 568.50M$ 651.10M$ 516.27M
Total Assets$ 1.82B$ 1.35B$ 1.80B$ 1.66B$ 1.69B
Total Debt$ 233.25M$ 229.33M$ 229.08M$ 222.11M$ 198.94M
Net Debt$ -816.32M$ -251.25M$ -339.42M$ -428.99M$ -317.33M
Total Liabilities$ 2.25B$ 2.22B$ 2.51B$ 2.34B$ 2.44B
Stockholders Equity$ -431.71M$ -867.08M$ -716.93M$ -678.35M$ -754.52M
Cash Flow-
Free Cash Flow$ 311.43M$ -90.48M-$ -57.86M$ -178.89M
Operating Cash Flow$ 314.30M$ -83.60M$ -176.80M$ -39.70M$ -171.92M
Investing Cash Flow$ -372.71M$ -7.25M$ -9.08M$ -18.39M$ -7.78M
Financing Cash Flow$ 258.22M$ 5.89M$ 100.39M$ 197.12M$ 61.34M
Currency in USD

Novavax Earnings and Revenue History

Novavax Debt to Assets

Novavax Cash Flow

Novavax Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis